Therapeutic Asset Ratings

3,774 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Ebx-102 Myelodysplastic Syndrome	Imperial College London	P2	CCC (51)
Hpc, Cord Blood Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P2	CCC (51)
HUMAN CULTURE EXPANDED GENETICALLY MODIFIED AUTOLOGOUS T CELLS FOR CELL-BASED GENE THERAPY. CELLS ARE DERIVED FROM ISOLATED BLOOD OF THE PATIENT AND ARE TRANSDUCED WITH NON-REPLICATIVE SELF-INACTIVATING (SIN) HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) BASED LENTIVIRAL VECTOR (LVV) PSEUDOTYPED WITH THE VESICULAR STOMATITIS VIRUS GLYCOPROTEIN G (VSV-G) ENVELOPE PROTEIN, AND ENCODING THE C11D5.3 ANTI-TNF RECEPTOR SUPERFAMILY MEMBER 17 (TNFRSF17, BCMA) SINGLE CHAIN VARIABLE FRAGMENT (SCFV) CD8/4-1BB/CD3ZETA CHIMERIC ANTIGEN RECEPTOR (CAR) UNDER THE TRANSCRIPTIONAL CONTROL OF THE MYELOPROLIFERATIVE SARCOMA VIRUS ENHANCER, NEGATIVE CONTROL REGION DELETED, DL587REV PRIMER-BINDING SITE SUBSTITUTED (MND) PROMOTE Large B-Cell Lymphoma	Masonic Cancer Center, University of Minnesota	P2	CCC (51)
Human Mesenchymal Stem Cells Cognitive Disorder	Bernard (Barry) Baumel	P2	CCC (51)
HUMAN PERIPHERAL BLOOD LEUKOCYTES B-Cell Non-Hodgkin Lymphoma	The First Affiliated Hospital of Soochow University	P2	CCC (51)
Jcar017 (Lisocabtagene Maraleucel) Lymphoma	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	P2	CCC (51)
Jwcar029 High Grade B-Cell Lymphoma	Shanghai Ming Ju Biotechnology Co., Ltd.	P2	CCC (51)
Jwcar029 Large B-Cell Lymphoma	Shanghai Ming Ju Biotechnology Co., Ltd.	P2	CCC (51)
Kras Tcr-Transduced Pbl Cholangiocarcinoma	National Cancer Institute (NCI)	P2	CCC (51)
Lifileucel Non-Small Cell Lung Carcinoma	Shanghai Juncell Therapeutics	P2	CCC (51)
lm103 tils Melanoma	Suzhou BlueHorse Therapeutics Co., Ltd.	P2	CCC (51)
Pbsc Acute Leukemia	Fred Hutchinson Cancer Center	P2	CCC (51)
Pbsc Acute Leukemia Of Ambiguous Lineage	Fred Hutchinson Cancer Center	P2	CCC (51)
Pbsc Chronic Myelomonocytic Leukemia	Fred Hutchinson Cancer Center	P2	CCC (51)
Pbsc Myelodysplastic Syndrome	Fred Hutchinson Cancer Center	P2	CCC (51)
Pd-L1 T-Hank Urothelial Carcinoma	ImmunityBio, Inc.	P2	CCC (51)
tcb008 Myelodysplastic Syndrome	TC Biopharm	P2	CCC (51)
Tcr Transduced T-Cells Neuroendocrine Neoplasm	National Cancer Institute (NCI)	P2	CCC (51)
TIL Mesothelioma	Udai Kammula	P2	CCC (51)
TIL Neuroendocrine Neoplasm	Udai Kammula	P2	CCC (51)
TIL Sarcoma	Udai Kammula	P2	CCC (51)
Tisagenlecleucel Large B-cell Lymphoma	Masonic Cancer Center, University of Minnesota	P2	CCC (51)
Wztl-002 Car T-Cells Large B-Cell Lymphoma	Malaghan Institute of Medical Research	P2	CCC (51)
Young Til Malignant Pancreatic Neoplasm	National Cancer Institute (NCI)	P2	CCC (51)
Adipose-Derived Stromal Vascular Fraction Cells Parkinson Disease	Samuel Vilchez, PhD	P1/2	CCC (51)

Showing 501 to 525 of 3,774 assets

PreviousPage 21 of 151Next